Hannah R Wardill Clinical Oncology Society of Australia Annual Scientific Meeting 2021

Abstracts this author is presenting:

• Anakinra is safe in HSCT recipients and reinforces the mucosal barrier to control acute complications of high-dose melphalan: results from the AFFECT-1 (Phase IIA) trial and preclinical efficacy study — e-Poster Listing